MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL

163 Ratings

Rs 18,225 Rs 13,500

26 % OFF

DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS OUTCOME. THIS ASSAY HELPS TO IDENTIFY PATIENTS AT HIGHER/LOWER RISK OF RELAPSE. DETECTION OF MINIMAL RESIDUAL DISEASE IS IMPORTANT FOR RISK ASSESSMENT AND STRATIFICATION OF THERAPY. IT DETECTS SUB MICROSCOPIC LEVELS OF LEUKEMIA WITH A CLINICAL SENSITIVITY OF 0.01%.

Why book with us?

  • Free and On Schedule Sample Collection
  • 24/7 Service
  • Affordable
  • Quick and Accurate Reports

3 ML (1 ML MIN.) FIRST PULL BONE MARROW ASPIRATE IN 1 GREEN TOP (SODIUM HEPARIN) TUBE AND 4 ML (3 ML MIN.) WHOLE BLOOD IN 1 GREEN TOP (SODIUM HEPARIN) TUBE. SHIP IMMEDIATELY AT 18-22 C. DO NOT REFRIGERATE OR FREEZE. IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY. ALL INFORMATION SHOULD BE GIVEN AT THE TIME OF REGISTRATION/BEFORE THE SAMPLE IS PROCESSED.

FLOW CYTOMETRY

REPORT ON 4TH DAY EVENING 7PM

IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY.

Get a Free Call

To Know about Services Detail or any Enquiry.

book health check